Come up with a name for your new list and we'll add to it:
Primorigen Biosciences raised a round of funding on August 07, 2006. Investors include
Louisiana Emerging Technology Center.
Primorigen develops, produces and aims to provide technical support for cell therapy research products, including well characterized antibodies, protein targets and microarrays to characterize the dev…